SRGA VS AKAN Stock Comparison
Performance
SRGA10/100
10/100
SRGA returned -94.30% in the last 12 months. Based on SPY's performance of -3.90%, its performance is below average giving it a score of 10 of 100.
AKAN10/100
10/100
AKAN returned -83.53% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.
Technicals
SRGA14/100
14/100
SRGA receives a 14 of 100 based on 14 indicators. 2 are bullish, 12 are bearish.
AKAN36/100
36/100
AKAN receives a 35 of 100 based on 14 indicators. 4 are bullish, 8 are bearish.
Earnings
SRGA44/100
44/100
SRGA has missed earnings 3 times in the last 20 quarters.
AKAN
"Earnings" not found for AKAN
Profit
SRGA35/100
35/100
Out of the last 20 quarters, SRGA has had 7 profitable quarters and has increased their profits year over year on 5 of them.
AKAN10/100
10/100
Out of the last 3 quarters, AKAN has had 1 profitable quarters and has increased their profits year over year on 0 of them.
Volatility
SRGA57/100
57/100
SRGA has had a higher than average amount of volatility over the last 12 months giving it a score of 57 of 100.
AKAN75/100
75/100
AKAN has had a higher than average amount of volatility over the last 12 months giving it a score of 75 of 100.
All score calculations are broken down here to help you make more informed investing decisions
Surgalign Holdings, Inc. Common Stock Summary
Nasdaq / SRGA
Healthcare
Medical Devices
Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. It offers products for thoracolumbar procedures, including Streamline TL Spinal Fixation system, a system for degenerative and complex spine procedures; and Streamline MIS Spinal Fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical plate system; Fortilink-C IBF system, a cervical interbody fusion device that utilizes TETRAfuse 3D technology; and Streamline OCT system, a range of implants used in the occipito-cervico-thoracic posterior spine. The company also provides motion preservation systems comprising Coflex Interlaminar Stabilization device for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; HPS 2.0 Universal Fixation system, a pedicle screw system used for posterior stabilization of the thoracolumbar spine; and SImmetry SI Joint Fusion system, a minimally invasive surgical implant system to decrease opioid use, pain, and disability. In addition, it develops Augmented Reality and Artificial Intelligence digital surgery platform to enable digital spine surgery. The company markets its products through independent spine and biomaterial distributors to hospitals, ambulatory surgery centers, and healthcare providers, as well as through direct sales force. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois.
Akanda Corp. Common Shares Summary
Nasdaq / AKAN
Healthcare
Drug Manufacturers - Specialty & Generic
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products in the United Kingdom, Lesotho, and internationally. It intends to supply cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.
Power up your portfolio
Build a portfolio of your favorite stocks
Pluto makes it easy to build investing strategies and automate your portfolio
Compare Similar Companies
Compare SRGA to other companies in the same or a similar industry.